137 related articles for article (PubMed ID: 12710199)
21. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
[TBL] [Abstract][Full Text] [Related]
22. Induction of anti-tumor immunity in mice using a syngeneic endothelial cell vaccine.
Scappaticci FA; Nolan GP
Anticancer Res; 2003; 23(2B):1165-72. PubMed ID: 12820367
[TBL] [Abstract][Full Text] [Related]
23. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
24. Anti-angiogenic potential of Gleditsia sinensis fruit extract.
Chow LM; Chui CH; Tang JC; Lau FY; Yau MY; Cheng GY; Wong RS; Lai PB; Leung TW; Teo IT; Cheung F; Guo D; Chan AS
Int J Mol Med; 2003 Aug; 12(2):269-73. PubMed ID: 12851730
[TBL] [Abstract][Full Text] [Related]
25. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
26. Re: Doussis-Anagnostopoulou et al. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease. J Pathol 2002; 197: 677-683.
Agarwal B; Naresh KN
J Pathol; 2003 Oct; 201(2):334-5. PubMed ID: 14517852
[No Abstract] [Full Text] [Related]
27. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of vascular endothelial growth factor and down-regulation of pigment epithelium-derived factor messenger ribonucleic acid levels in leptin-exposed cultured retinal pericytes.
Yamagishi S; Inagaki Y; Amano S; Okamoto T; Takeuchi M
Int J Tissue React; 2002; 24(4):137-42. PubMed ID: 12779248
[TBL] [Abstract][Full Text] [Related]
29. Quantitative assessment of angiogenic responses by the directed in vivo angiogenesis assay.
Guedez L; Rivera AM; Salloum R; Miller ML; Diegmueller JJ; Bungay PM; Stetler-Stevenson WG
Am J Pathol; 2003 May; 162(5):1431-9. PubMed ID: 12707026
[TBL] [Abstract][Full Text] [Related]
30. VEGFs, angiopoietins, Ephrins and their receptors: putative targets for tumor therapy?
Marmé D
Ann Hematol; 2002; 81 Suppl 2():S66. PubMed ID: 12611080
[No Abstract] [Full Text] [Related]
31. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
32. Anti-tumor actions of major component 3'-O-acetylhamaudol of Angelica japonica roots through dual actions, anti-angiogenesis and intestinal intraepithelial lymphocyte activation.
Kimura Y; Sumiyoshi M; Baba K
Cancer Lett; 2008 Jun; 265(1):84-97. PubMed ID: 18358599
[TBL] [Abstract][Full Text] [Related]
33. Long-term expression of angiostatin suppresses metastatic liver cancer in mice.
Xu R; Sun X; Tse LY; Li H; Chan PC; Xu S; Xiao W; Kung HF; Krissansen GW; Fan ST
Hepatology; 2003 Jun; 37(6):1451-60. PubMed ID: 12774025
[TBL] [Abstract][Full Text] [Related]
34. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
He GA; Luo JX; Zhang TY; Hu ZS; Wang FY
Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609
[TBL] [Abstract][Full Text] [Related]
35. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
36. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
[TBL] [Abstract][Full Text] [Related]
37. Tumor microvascular changes to anti-angiogenic treatment assessed by MR contrast media of different molecular weights.
Roberts TP; Turetschek K; Preda A; Novikov V; Moeglich M; Shames DM; Brasch RC; Weinmann HJ
Acad Radiol; 2002 Aug; 9 Suppl 2():S511-3. PubMed ID: 12188324
[No Abstract] [Full Text] [Related]
38. Tipping the balance for angiogenic disorders.
Gao G; Ma J
Drug Discov Today; 2002 Feb; 7(3):171-2. PubMed ID: 11815230
[No Abstract] [Full Text] [Related]
39. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
Schmid G; Guba M; Ischenko I; Papyan A; Joka M; Schrepfer S; Bruns CJ; Jauch KW; Heeschen C; Graeb C
J Cell Biochem; 2007 May; 101(1):259-70. PubMed ID: 17203465
[TBL] [Abstract][Full Text] [Related]
40. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice.
Bauer TW; Fan F; Liu W; Camp ER; Yang A; Somcio RJ; Bucana CD; Singh R; Ellis LM
Ann Surg Oncol; 2007 Oct; 14(10):2838-46. PubMed ID: 17653802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]